DarioHealth Corp. (DRIO) vs OptimizeRx Corp. (OPRX)
DarioHealth Corp. and OptimizeRx Corp. are both Health Information Services companies. OptimizeRx Corp. is the larger, with a market value of $148.6M against $66.3M — 2.2× the size. DarioHealth Corp. has negative trailing earnings, so its P/E is not meaningful; OptimizeRx Corp. trades at 33.4×. OptimizeRx Corp. grew revenue faster over the last twelve months: −5.82% against −22.7%. OptimizeRx Corp. has the higher net margin (4.66% vs −215.6%) and the higher return on invested capital (5.41% vs −27.7%). Across the 18 metrics below, OptimizeRx Corp. leads on 15 and DarioHealth Corp. on 3.
Valuation
Profitability
| Metric | DRIO | OPRX | Health Information Services median |
|---|---|---|---|
| Gross margin | 58.15% | 73.22% | 63.38% |
| Operating margin | (151.60%) | 11.04% | (8.35%) |
| Net margin | (215.63%) | 4.66% | (14.70%) |
| Free cash flow margin | (121.32%) | 18.83% | 0.58% |
| Return on equity | (76.05%) | 3.68% | (6.82%) |
| Return on assets | (44.19%) | 2.76% | (6.02%) |
| Return on invested capital | (27.67%) | 5.41% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack